Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.3 trillion and total revenue of $109.84 billion.
Market Cap
1.3T
Revenue
109.84B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.59%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 129.39B | -2.38% | 773,572 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.44B | -1.72% | 275,104 | 14.92B |
| 3 | ARGX | argenx SE | 56.71B | -1.13% | 155,477 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.19B | -0.01% | 258,574 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.34B | -1.12% | 593,322 | - |
| 6 | RPRX | Royalty Pharma plc | 33.61B | 1.18% | 1,510,219 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 33.56B | -3.00% | 184,278 | 5.74B |
| 8 | MRNA | Moderna, Inc. | 29.54B | -6.66% | 4,099,997 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.96B | -0.61% | 4,266,797 | 8.26M |
| 10 | INSM | Insmed Incorporated | 24.97B | 2.08% | 1,318,726 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.43B | -1.73% | 308,846 | 3.23B |
| 12 | INCY | Incyte Corporation | 23.33B | -1.07% | 675,184 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.71B | - | 1,826,586 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.98B | 2.40% | 229,452 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.59B | -0.81% | 297,615 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.36B | -1.02% | 730,886 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.10B | -1.70% | 1,777,375 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.96B | -2.18% | 756,270 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.04B | 0.21% | 113,967 | 1.13B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.75B | -0.79% | 271,255 | 708.24M |
| 21 | SMMT | Summit Therapeutics Inc. | 12.12B | -1.67% | 1,046,025 | - |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.06B | -1.59% | 617,154 | 622.01M |
| 23 | ABVX | ABIVAX Société Anonyme | 12.00B | -2.15% | 773,242 | 5.67M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 11.58B | -0.72% | 574,643 | 3.24B |
| 25 | CYTK | Cytokinetics, Incorporated | 11.29B | -2.78% | 984,159 | 105.82M |
| 26 | TECH | Bio-Techne Corporation | 10.99B | -0.08% | 3,515,115 | 1.21B |
| 27 | KRYS | Krystal Biotech, Inc. | 10.90B | 0.29% | 92,269 | 417.30M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.00B | -0.04% | 810,481 | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.98B | -1.17% | 1,036,995 | 769.10M |
| 30 | NUVL | Nuvalent, Inc. | 9.82B | 0.04% | 413,278 | - |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.39B | -4.26% | 787,845 | 51.48M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.35B | -3.33% | 869,987 | 1.51B |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 9.28B | 1.88% | 296,838 | 7.46M |
| 34 | IBRX | ImmunityBio, Inc. | 9.10B | -0.86% | 6,457,763 | 140.98M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 9.01B | -2.80% | 196,048 | 74.06M |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.80B | -0.04% | 10,556,084 | 18.07M |
| 37 | PCVX | Vaxcyte, Inc. | 8.31B | -5.11% | 549,346 | - |
| 38 | IMVT | Immunovant, Inc. | 8.28B | -1.90% | 429,171 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 8.11B | -2.35% | 946,836 | 700.35M |
| 40 | SYRE | Spyre Therapeutics, Inc. | 8.00B | -2.23% | 362,218 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.84B | 0.20% | 823,103 | 569.61M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.76B | -1.12% | 261,310 | 217.17M |
| 43 | PTCT | PTC Therapeutics, Inc. | 7.34B | -0.75% | 404,795 | 827.11M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.83B | -0.10% | 3,639,072 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.76B | 2.45% | 1,374,296 | 7.50M |
| 46 | SRRK | Scholar Rock Holding Corporation | 6.63B | -2.16% | 332,757 | - |
| 47 | LGND | Ligand Pharmaceuticals Incorporated | 6.24B | -1.32% | 160,199 | 274.48M |
| 48 | CGON | CG Oncology, Inc. | 6.16B | 0.33% | 451,926 | 5.07M |
| 49 | DFTX | Definium Therapeutics, Inc. | 6.02B | 1.89% | 2,615,863 | - |
| 50 | BLTE | Belite Bio, Inc | 5.90B | -4.81% | 97,288 | - |
| 51 | ERAS | Erasca, Inc. | 5.87B | 0.33% | 3,314,765 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.71B | -2.58% | 1,219,864 | 4.10M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.43B | -1.30% | 683,304 | 536.20M |
| 54 | CELC | Celcuity Inc. | 5.38B | -4.60% | 599,691 | - |
| 55 | LEGN | Legend Biotech Corporation | 5.30B | -0.96% | 552,163 | 1.14B |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 5.20B | -0.73% | 312,383 | 1.34M |
| 57 | ORKA | Oruka Therapeutics, Inc. | 5.09B | -2.60% | 515,577 | - |
| 58 | MANE | Veradermics, Incorporated | 4.94B | 1.24% | 350,350 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.90B | 5.50% | 908,345 | - |
| 60 | CAI | Caris Life Sciences, Inc. | 4.89B | -1.00% | 2,817,197 | 907.29M |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.58B | -6.42% | 1,652,322 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | -0.76% | 1,526,070 | 1.10B |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.43B | 0.23% | 2,020,159 | 56.99M |
| 64 | DNLI | Denali Therapeutics Inc. | 4.24B | 0.19% | 543,435 | - |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 4.13B | -4.49% | 281,995 | 22.57M |
| 66 | RLAY | Relay Therapeutics, Inc. | 4.10B | -4.61% | 1,698,280 | 10.68M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.94B | - | 2,528,243 | - |
| 68 | PBLS | Parabilis Medicines, Inc. | 3.93B | 1.58% | 399,163 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.90B | -3.65% | 312,862 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.89B | -2.73% | 115,227 | 803.79M |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.02% | 311,568 | 596.96M |
| 72 | ALMS | Alumis Inc. | 3.79B | 1.61% | 2,712,799 | 8.40M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.75B | -1.55% | 309,580 | 236.00M |
| 74 | BEAM | Beam Therapeutics Inc. | 3.66B | -2.99% | 2,832,140 | 164.01M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.60B | -6.64% | 648,864 | 225.27M |
| 76 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -3.46% | 463,850 | - |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | 1.15% | 754,082 | 415.62M |
| 78 | RARE | Ultragenyx Pharmaceutical Inc. | 3.40B | -3.35% | 2,771,572 | 670.00M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.08B | -1.68% | 751,938 | 865.00K |
| 80 | VERA | Vera Therapeutics, Inc. | 3.05B | -3.39% | 2,257,873 | - |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 3.01B | -0.91% | 279,332 | 535.08M |
| 82 | IRON | Disc Medicine, Inc. | 3.00B | -1.55% | 220,006 | - |
| 83 | MBX | MBX Biosciences, Inc. | 2.94B | -0.42% | 1,469,433 | - |
| 84 | QURE | uniQure N.V. | 2.90B | 2.03% | 661,554 | 18.09M |
| 85 | KLRA | Kailera Therapeutics, Inc. | 2.82B | -2.16% | 812,818 | - |
| 86 | IMNM | Immunome, Inc. | 2.75B | -0.37% | 755,024 | 4.02M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.62B | -2.25% | 575,813 | - |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.60B | -6.21% | 1,265,266 | - |
| 89 | AGIO | Agios Pharmaceuticals, Inc. | 2.58B | -1.50% | 648,565 | 66.05M |
| 90 | NRIX | Nurix Therapeutics, Inc. | 2.51B | -2.40% | 486,892 | 71.78M |
| 91 | BHVN | Biohaven Ltd. | 2.51B | 7.01% | 3,804,521 | - |
| 92 | NKTR | Nektar Therapeutics | 2.48B | -2.14% | 326,752 | 55.63M |
| 93 | PHVS | Pharvaris N.V. | 2.44B | 1.10% | 458,541 | - |
| 94 | KOD | Kodiak Sciences Inc. | 2.43B | 1.61% | 367,980 | - |
| 95 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | -8.85% | 10,750,188 | - |
| 96 | VCEL | Vericel Corporation | 2.40B | 0.15% | 704,792 | 292.09M |
| 97 | NTLA | Intellia Therapeutics, Inc. | 2.32B | -4.93% | 1,863,080 | 66.09M |
| 98 | VRDN | Viridian Therapeutics, Inc. | 2.19B | -4.45% | 684,904 | 70.92M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.19B | -1.06% | 334,206 | 899.11M |
| 100 | OCUL | Ocular Therapeutix, Inc. | 2.19B | -3.39% | 1,536,857 | 52.04M |
| 101 | SNDX | Syndax Pharmaceuticals, Inc. | 2.18B | 5.64% | 1,284,117 | 217.17M |
| 102 | ZLAB | Zai Lab Limited | 2.17B | -0.16% | 943,803 | 453.28M |
| 103 | ABCL | AbCellera Biologics Inc. | 2.17B | -7.67% | 9,369,295 | 79.21M |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | 2.12% | 3,185,872 | 2.18B |
| 105 | ADMA | ADMA Biologics, Inc. | 2.12B | -0.54% | 2,278,218 | 509.86M |
| 106 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.73% | 663,103 | 298.30M |
| 107 | TSHA | Taysha Gene Therapies, Inc. | 2.08B | -0.15% | 2,606,411 | 7.47M |
| 108 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -1.87% | 57,172 | - |
| 109 | GENB | Generate Biomedicines, Inc. | 2.03B | -2.16% | 804,167 | 30.30M |
| 110 | LKFT | Lakefront Biotherapeutics NV | 2.01B | 0.75% | 98,746 | 1.20B |
| 111 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 1.83% | 154,070 | 20.00M |
| 112 | GLUE | Monte Rosa Therapeutics, Inc. | 2.00B | -3.16% | 582,377 | 42.95M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.99B | -3.00% | 201,152 | 32.08M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.99B | -2.03% | 266,004 | - |
| 115 | KARD | Kardigan, Inc. | 1.99B | -6.76% | 652,955 | - |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.97B | -4.56% | 15,617,822 | 66.41M |
| 117 | NUVB | Nuvation Bio Inc. | 1.95B | -1.06% | 4,941,609 | 143.05M |
| 118 | PGEN | Precigen, Inc. | 1.94B | -1.18% | 1,586,701 | 31.60M |
| 119 | ANAB | AnaptysBio, Inc. | 1.93B | -1.96% | 251,968 | 232.39M |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.93B | 1.85% | 602,280 | - |
| 121 | NBTX | Nanobiotix S.A. | 1.93B | -0.13% | 35,998 | 38.27M |
| 122 | IOVA | Iovance Biotherapeutics, Inc. | 1.91B | -1.72% | 6,873,358 | 285.61M |
| 123 | ZYME | Zymeworks Inc. | 1.91B | -2.69% | 197,571 | 81.26M |
| 124 | ATAI | AtaiBeckley Inc. | 1.91B | -0.19% | 7,806,443 | 3.49M |
| 125 | BCAX | Bicara Therapeutics Inc. | 1.90B | -4.64% | 867,122 | - |
| 126 | ABSI | Absci Corporation | 1.88B | -7.68% | 3,295,371 | 1.84M |
| 127 | GHRS | GH Research PLC | 1.84B | -0.15% | 186,104 | - |
| 128 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.92% | 795,208 | 10.00M |
| 129 | URGN | UroGen Pharma Ltd. | 1.81B | -1.39% | 246,924 | 140.49M |
| 130 | MESO | Mesoblast Limited | 1.81B | -3.22% | 70,131 | 65.38M |
| 131 | VIR | Vir Biotechnology, Inc. | 1.76B | -0.63% | 519,920 | 65.50M |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.76B | -3.26% | 468,166 | 20.00M |
| 133 | MPLT | MapLight Therapeutics, Inc. | 1.75B | 3.97% | 373,881 | - |
| 134 | DMRA | Damora Therapeutics, Inc. | 1.69B | -8.23% | 678,855 | - |
| 135 | IMCR | Immunocore Holdings plc | 1.69B | -0.63% | 190,148 | 412.81M |
| 136 | INVA | Innoviva, Inc. | 1.66B | 1.30% | 206,309 | 420.69M |
| 137 | SEPN | Septerna, Inc. | 1.65B | 2.12% | 287,730 | 72.26M |
| 138 | AAPG | Ascentage Pharma Group International | 1.63B | 0.96% | 7,625 | 82.08M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.61B | -3.40% | 395,329 | 2.71B |
| 140 | AKTS | Aktis Oncology, Inc. | 1.59B | 4.02% | 711,739 | 8.28M |
| 141 | COAG | Hemab Therapeutics Holdings, Inc. | 1.58B | 7.62% | 347,135 | - |
| 142 | SVRA | Savara Inc. | 1.58B | 0.32% | 543,606 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.55B | -1.72% | 419,325 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.54B | -3.22% | 424,475 | - |
| 145 | NVAX | Novavax, Inc. | 1.54B | -1.16% | 3,780,148 | 596.34M |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.48B | -3.46% | 750,035 | 204.73M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.42B | -4.03% | 230,665 | 1.30M |
| 148 | IMTX | Immatics N.V. | 1.35B | -3.46% | 252,800 | 43.00M |
| 149 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 2.88% | 2,610,001 | - |
| 150 | ARDX | Ardelyx, Inc. | 1.34B | -0.28% | 1,290,439 | 427.68M |
| 151 | JBIO | Jade Biosciences, Inc. | 1.34B | 0.36% | 857,284 | - |
| 152 | MNKD | MannKind Corporation | 1.31B | 0.59% | 1,959,492 | 360.78M |
| 153 | MGTX | MeiraGTx Holdings plc | 1.31B | -3.55% | 804,818 | 79.76M |
| 154 | CAPR | Capricor Therapeutics, Inc. | 1.29B | 0.14% | 1,456,079 | 11.13M |
| 155 | AVLN | Avalyn Pharma Inc. | 1.28B | 1.83% | 419,968 | - |
| 156 | XNCR | Xencor, Inc. | 1.22B | 0.96% | 307,919 | 97.36M |
| 157 | WVE | Wave Life Sciences Ltd. | 1.21B | -1.80% | 969,791 | 71.80M |
| 158 | SANA | Sana Biotechnology, Inc. | 1.19B | -3.40% | 3,369,588 | - |
| 159 | EYPT | EyePoint, Inc. | 1.17B | -0.07% | 1,897,267 | 7.61M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.15B | -0.27% | 317,905 | - |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 16.62% | 223,376 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | -1.21% | 251,873 | - |
| 163 | VOR | Vor Biopharma Inc. | 1.10B | 1.04% | 2,135,349 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | -3.81% | 708,371 | - |
| 165 | KURA | Kura Oncology, Inc. | 1.08B | 1.08% | 1,916,981 | 71.64M |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | -5.46% | 795,262 | - |
| 167 | SLDB | Solid Biosciences Inc. | 1.06B | -3.14% | 697,009 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 1.03B | 0.48% | 1,222,432 | 191.45M |
| 169 | JANX | Janux Therapeutics, Inc. | 1.02B | 3.16% | 1,364,554 | 13.73M |
| 170 | IVA | Inventiva S.A. | 1.01B | -5.59% | 1,867,338 | 7.94M |
| 171 | PHAR | Pharming Group N.V. | 1.01B | -1.11% | 6,273 | 369.49M |
| 172 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -0.21% | 1,296,627 | 59.00K |
| 173 | GERN | Geron Corporation | 1.00B | 2.35% | 5,930,180 | 196.12M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 986.12M | -6.33% | 1,482,403 | 69.64M |
| 175 | LBRX | LB Pharmaceuticals Inc | 979.88M | -0.35% | 305,712 | - |
| 176 | ANNX | Annexon, Inc. | 977.32M | -7.23% | 5,274,797 | - |
| 177 | DBVT | DBV Technologies S.A. | 971.65M | -3.46% | 137,321 | 5.74M |
| 178 | DSGN | Design Therapeutics, Inc. | 954.34M | 3.87% | 1,036,385 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | 2.77% | 627,801 | 204.89M |
| 180 | REPL | Replimune Group, Inc. | 916.68M | -5.13% | 1,505,050 | - |
| 181 | ANRO | Alto Neuroscience, Inc. | 915.60M | -0.93% | 335,717 | - |
| 182 | TBPH | Theravance Biopharma, Inc. | 881.08M | -0.12% | 230,268 | 109.78M |
| 183 | TENX | Tenax Therapeutics, Inc. | 871.63M | -1.84% | 651,953 | - |
| 184 | ZVRA | Zevra Therapeutics, Inc. | 839.81M | -1.62% | 435,040 | 122.29M |
| 185 | OCS | Oculis Holding AG | 827.32M | 0.15% | 198,897 | 1.40M |
| 186 | PRME | Prime Medicine, Inc. | 813.68M | 12.91% | 7,353,078 | 4.03M |
| 187 | CTMX | CytomX Therapeutics, Inc. | 802.24M | -4.04% | 828,071 | 35.54M |
| 188 | RIGL | Rigel Pharmaceuticals, Inc. | 794.11M | 0.85% | 306,754 | 299.77M |
| 189 | RGNX | REGENXBIO Inc. | 787.37M | 1.40% | 2,385,550 | 87.82M |
| 190 | SPRY | ARS Pharmaceuticals, Inc. | 783.50M | -3.66% | 1,122,767 | 98.99M |
| 191 | AURA | Aura Biosciences, Inc. | 783.13M | 1.00% | 645,990 | - |
| 192 | IMMX | Immix Biopharma, Inc. | 783.09M | -8.49% | 2,428,192 | - |
| 193 | CLYM | Climb Bio, Inc. | 777.03M | 1.12% | 1,401,352 | - |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 775.13M | -1.25% | 535,197 | 8.37M |
| 195 | ODTX | Odyssey Therapeutics, Inc. | 744.98M | -1.70% | 106,712 | 1.06M |
| 196 | OMER | Omeros Corporation | 741.12M | 0.34% | 571,904 | 9.89M |
| 197 | ALLO | Allogene Therapeutics, Inc. | 731.73M | -1.40% | 12,389,497 | 22.00K |
| 198 | NGNE | Neurogene Inc. | 729.82M | -0.48% | 299,369 | 925.00K |
| 199 | TRAX | First Tracks Biotherapeutics, Inc. | 724.71M | 5.01% | 551,677 | - |
| 200 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 722.57M | 8.81% | 722,528 | - |
| 201 | FTH | Faeth Therapeutics, Inc. | 722.32M | 7.32% | 99,485 | - |
| 202 | CADL | Candel Therapeutics, Inc. | 707.42M | -1.98% | 890,654 | - |
| 203 | SLBT | SL Science Holding Limited | 701.45M | -2.69% | 71,804 | - |
| 204 | CRMD | CorMedix Inc. | 691.16M | -0.68% | 401,068 | 400.05M |
| 205 | SGP | SpyGlass Pharma, Inc. | 684.05M | 4.82% | 140,851 | - |
| 206 | FDMT | 4D Molecular Therapeutics, Inc. | 680.64M | 1.56% | 757,145 | 88.24M |
| 207 | RLMD | Relmada Therapeutics, Inc. | 672.35M | 0.47% | 721,091 | - |
| 208 | TECX | Tectonic Therapeutic, Inc. | 669.76M | -2.86% | 118,886 | - |
| 209 | MNPR | Monopar Therapeutics Inc. | 664.99M | 4.25% | 297,962 | - |
| 210 | DRUG | Bright Minds Biosciences Inc. | 663.93M | 0.93% | 147,069 | - |
| 211 | MDXG | MiMedx Group, Inc. | 638.98M | 2.14% | 578,215 | 389.42M |
| 212 | ACHV | Achieve Life Sciences, Inc. | 635.97M | -4.98% | 1,093,542 | - |
| 213 | AGMB | AgomAb Therapeutics NV | 627.42M | -4.07% | 45,474 | - |
| 214 | GYRE | Gyre Therapeutics, Inc. | 621.33M | -3.00% | 65,069 | 117.05M |
| 215 | ALT | Altimmune, Inc. | 604.81M | 2.98% | 3,499,454 | 36.00K |
| 216 | KYTX | Kyverna Therapeutics, Inc. | 597.01M | 1.45% | 659,299 | - |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 592.49M | -5.25% | 661,239 | 151.40M |
| 218 | NVCT | Nuvectis Pharma, Inc. | 591.10M | -3.46% | 141,174 | - |
| 219 | CTNM | Contineum Therapeutics, Inc. | 585.10M | 7.49% | 596,004 | - |
| 220 | EIKN | Eikon Therapeutics, Inc. | 580.37M | -7.59% | 527,941 | - |
| 221 | ASMB | Assembly Biosciences, Inc. | 569.35M | -0.81% | 135,958 | 71.10M |
| 222 | PROK | ProKidney Corp. | 567.87M | -3.59% | 409,278 | 889.00K |
| 223 | XOMA | XOMA Royalty Corporation | 564.35M | 2.28% | 86,880 | 48.56M |
| 224 | EDIT | Editas Medicine, Inc. | 563.20M | -2.13% | 2,454,160 | 38.69M |
| 225 | CBIO | Crescent Biopharma, Inc. | 560.91M | -0.88% | 177,156 | 11.88M |
| 226 | ARVN | Arvinas, Inc. | 550.37M | -0.70% | 245,841 | 89.40M |
| 227 | STRO | Sutro Biopharma, Inc. | 536.55M | 0.78% | 249,901 | 99.61M |
| 228 | STTK | Shattuck Labs, Inc. | 527.56M | -5.23% | 1,033,360 | 1.00M |
| 229 | FBRX | Forte Biosciences, Inc. | 522.19M | -3.96% | 323,849 | - |
| 230 | ZURA | Zura Bio Limited | 521.54M | 8.07% | 1,174,194 | - |
| 231 | CABA | Cabaletta Bio, Inc. | 510.36M | -2.58% | 5,328,339 | - |
| 232 | OVID | Ovid Therapeutics Inc. | 509.53M | -1.09% | 3,026,985 | 7.12M |
| 233 | RZLT | Rezolute, Inc. | 508.75M | -2.01% | 594,338 | - |
| 234 | PRTA | Prothena Corporation plc | 508.09M | 0.26% | 168,335 | 57.94M |
| 235 | PRLD | Prelude Therapeutics Incorporated | 507.79M | 3.02% | 272,468 | 16.72M |
| 236 | OCGN | Ocugen, Inc. | 507.78M | - | 7,553,879 | 4.47M |
| 237 | VALN | Valneva SE | 493.63M | 0.76% | 8,898 | 180.25M |
| 238 | EVMN | Evommune, Inc. | 477.24M | -0.67% | 1,142,281 | 10.00M |
| 239 | CCCC | C4 Therapeutics, Inc. | 463.28M | -3.68% | 6,695,984 | 34.86M |
| 240 | RCKT | Rocket Pharmaceuticals, Inc. | 462.98M | 1.11% | 1,438,048 | - |
| 241 | AUTL | Autolus Therapeutics plc | 452.44M | 5.59% | 1,653,855 | 92.62M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.39M | 2.26% | 132,135 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 449.01M | -2.75% | 29,076 | - |
| 244 | SLN | Silence Therapeutics plc | 448.96M | -6.35% | 167,132 | 839.00K |
| 245 | ARTV | Artiva Biotherapeutics, Inc. | 445.07M | -3.38% | 205,016 | 251.00K |
| 246 | SGMT | Sagimet Biosciences Inc. | 444.61M | -6.37% | 380,736 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 435.56M | 4.55% | 718,755 | 109.16M |
| 248 | VTVT | vTv Therapeutics Inc. | 429.74M | -0.09% | 36,007 | 36.84M |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 426.22M | -1.00% | 131,848 | - |
| 250 | CMPX | Compass Therapeutics, Inc. | 421.41M | -4.09% | 1,650,127 | 850.00K |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 421.35M | 1.12% | 45,998 | 69.21M |
| 252 | UPB | Upstream Bio, Inc. | 421.21M | -1.53% | 198,344 | 3.32M |
| 253 | VSTM | Verastem, Inc. | 416.08M | -2.37% | 1,848,786 | 49.59M |
| 254 | PBYI | Puma Biotechnology, Inc. | 414.32M | 2.26% | 196,778 | 227.18M |
| 255 | ANL | Adlai Nortye Ltd. | 407.20M | -5.66% | 147,906 | 5.00M |
| 256 | VNDA | Vanda Pharmaceuticals Inc. | 395.69M | 2.97% | 1,223,895 | 217.78M |
| 257 | LXEO | Lexeo Therapeutics, Inc. | 390.25M | 3.76% | 485,873 | - |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 388.13M | -0.61% | 193,072 | - |
| 259 | VCRE | Vicore Pharma Holding AB (publ) | 386.95M | -5.85% | 36,969 | 370.61K |
| 260 | HELP | Cybin Inc. | 386.16M | 3.32% | 1,055,295 | - |
| 261 | ABEO | Abeona Therapeutics Inc. | 382.72M | 2.52% | 852,044 | 14.54M |
| 262 | LRMR | Larimar Therapeutics, Inc. | 376.82M | 1.47% | 1,014,707 | - |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 373.51M | -1.02% | 199,558 | 9.01M |
| 264 | LYEL | Lyell Immunopharma, Inc. | 359.34M | -6.22% | 112,765 | 31.00K |
| 265 | IMRX | Immuneering Corporation | 357.78M | 5.34% | 860,885 | - |
| 266 | FENC | Fennec Pharmaceuticals Inc. | 356.05M | -2.38% | 154,811 | 51.00M |
| 267 | FHTX | Foghorn Therapeutics Inc. | 355.22M | 0.83% | 450,135 | 28.22M |
| 268 | ZNTL | Zentalis Pharmaceuticals, Inc. | 345.97M | 1.67% | 1,018,945 | 26.87M |
| 269 | PALI | Palisade Bio, Inc. | 344.56M | -4.57% | 1,161,554 | - |
| 270 | IKT | Inhibikase Therapeutics, Inc. | 341.70M | -2.20% | 476,532 | 1.00 |
| 271 | FATE | Fate Therapeutics, Inc. | 341.52M | -4.14% | 1,099,346 | 6.32M |
| 272 | OABI | OmniAb, Inc. | 333.44M | 1.08% | 482,205 | 28.94M |
| 273 | LCTX | Lineage Cell Therapeutics, Inc. | 327.83M | -0.38% | 628,840 | 14.78M |
| 274 | IRD | Opus Genetics, Inc. | 327.21M | -0.74% | 403,603 | 11.98M |
| 275 | ALXO | ALX Oncology Holdings Inc. | 318.91M | 0.42% | 705,867 | - |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 306.24M | 0.80% | 830,116 | - |
| 277 | NMRA | Neumora Therapeutics, Inc. | 302.94M | -5.49% | 699,614 | - |
| 278 | IFRX | InflaRx N.V. | 302.69M | -3.07% | 987,697 | 33.82K |
| 279 | BCYC | Bicycle Therapeutics plc | 298.79M | -3.88% | 142,463 | 63.50M |
| 280 | GALT | Galectin Therapeutics Inc. | 297.01M | -2.17% | 318,481 | - |
| 281 | SABS | SAB Biotherapeutics, Inc. | 295.15M | -1.03% | 386,772 | 114.70K |
| 282 | RNAC | Cartesian Therapeutics, Inc. | 291.76M | -1.19% | 38,551 | 1.78M |
| 283 | MGNX | MacroGenics, Inc. | 291.44M | -3.47% | 339,068 | 157.08M |
| 284 | INDP | Indaptus Therapeutics, Inc. | 277.44M | -8.24% | 119,774 | - |
| 285 | GLSI | Greenwich LifeSciences, Inc. | 276.98M | 1.62% | 168,687 | - |
| 286 | CNXU | Conexeu Sciences Inc. | 274.01M | 7.90% | 157,631 | - |
| 287 | TTRX | Turn Therapeutics Inc. | 273.75M | -5.36% | 360,886 | - |
| 288 | NAGE | Niagen Bioscience, Inc. | 268.96M | -2.32% | 1,005,325 | 130.42M |
| 289 | TRDA | Entrada Therapeutics, Inc. | 262.50M | -2.21% | 171,863 | 5.74M |
| 290 | SRZN | Surrozen, Inc. | 260.19M | -2.61% | 38,943 | 7.49M |
| 291 | ADAG | Adagene Inc. | 259.67M | - | 243,964 | 7.67M |
| 292 | IVVD | Invivyd, Inc. | 254.57M | -8.25% | 1,186,667 | 55.87M |
| 293 | NKTX | Nkarta, Inc. | 251.12M | 3.85% | 400,130 | - |
| 294 | ACIU | AC Immune SA | 250.48M | -0.59% | 61,421 | 4.62M |
| 295 | FULC | Fulcrum Therapeutics, Inc. | 249.21M | -0.80% | 2,559,990 | 80.00M |
| 296 | AVXL | Anavex Life Sciences Corp. | 248.82M | -0.92% | 358,234 | - |
| 297 | CHRS | Coherus Oncology, Inc. | 247.57M | -3.89% | 807,223 | 46.88M |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 244.39M | -5.66% | 28,028 | 18.47M |
| 299 | DTIL | Precision BioSciences, Inc. | 239.44M | -2.11% | 388,527 | 45.07M |
| 300 | QTTB | Q32 Bio Inc. | 238.75M | -1.54% | 209,808 | 53.74M |
| 301 | KPTI | Karyopharm Therapeutics Inc. | 238.19M | 4.58% | 459,688 | 151.12M |
| 302 | CDXS | Codexis, Inc. | 236.33M | - | 536,012 | 78.09M |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 232.34M | -2.02% | 122,673 | 32.72M |
| 304 | TARA | Protara Therapeutics, Inc. | 231.00M | -4.45% | 229,286 | - |
| 305 | RNA | Atrium Therapeutics, Inc. | 228.70M | 0.98% | 157,821 | 36.68M |
| 306 | CGEN | Compugen Ltd. | 228.42M | 1.05% | 209,917 | 72.66M |
| 307 | PRQR | ProQR Therapeutics N.V. | 226.50M | -3.31% | 1,042,611 | 15.73M |
| 308 | NAUT | Nautilus Biotechnology, Inc. | 226.20M | 5.33% | 609,162 | - |
| 309 | KROS | Keros Therapeutics, Inc. | 225.23M | -2.32% | 83,758 | 33.18M |
| 310 | NBP | NovaBridge Biosciences | 223.20M | -4.46% | 1,155,255 | - |
| 311 | VYGR | Voyager Therapeutics, Inc. | 220.24M | -3.57% | 270,069 | 36.49M |
| 312 | CLLS | Cellectis S.A. | 219.02M | -2.80% | 3,479 | 75.11M |
| 313 | CAMP | Camp4 Therapeutics Corporation | 217.57M | -4.77% | 166,558 | 3.93M |
| 314 | NERV | Minerva Neurosciences, Inc. | 213.14M | -4.09% | 39,350 | - |
| 315 | WHWK | Whitehawk Therapeutics, Inc. | 212.98M | -4.58% | 924,931 | 7.15M |
| 316 | KRRO | Korro Bio, Inc. | 207.83M | -0.55% | 104,607 | 3.84M |
| 317 | CRBU | Caribou Biosciences, Inc. | 205.80M | 8.07% | 2,573,420 | 11.20M |
| 318 | ALEC | Alector, Inc. | 203.73M | -4.92% | 207,940 | 18.42M |
| 319 | ARCT | Arcturus Therapeutics Holdings Inc. | 202.45M | -6.28% | 236,284 | 54.71M |
| 320 | HUMA | Humacyte, Inc. | 200.69M | -3.45% | 3,107,557 | 2.02M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 199.40M | -1.58% | 339,014 | 17.56M |
| 322 | IMUX | Immunic, Inc. | 197.51M | -5.60% | 50,337 | - |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 197.18M | 4.86% | 166,842 | - |
| 324 | OTLK | Outlook Therapeutics, Inc. | 197.18M | 11.74% | 9,125,086 | 333.14K |
| 325 | NGEN | NervGen Pharma Corp. | 196.48M | -7.96% | 1,465,415 | - |
| 326 | PLX | Protalix BioTherapeutics, Inc. | 193.77M | 1.91% | 293,599 | 76.38M |
| 327 | TNYA | Tenaya Therapeutics, Inc. | 190.94M | -4.36% | 3,869,017 | 225.00K |
| 328 | MDWD | MediWound Ltd. | 188.93M | -1.61% | 78,523 | 14.48M |
| 329 | EQ | Equillium, Inc. | 185.89M | 2.08% | 196,560 | 4.39M |
| 330 | LENZ | LENZ Therapeutics, Inc. | 185.15M | 0.08% | 445,838 | 20.99M |
| 331 | ARMP | Armata Pharmaceuticals, Inc. | 184.29M | -5.46% | 79,502 | 5.20M |
| 332 | OKUR | OnKure Therapeutics, Inc. | 182.59M | 3.20% | 116,893 | - |
| 333 | ACOG | Alpha Cognition Inc. | 177.46M | 0.62% | 82,838 | 10.83M |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 177.01M | 0.58% | 130,987 | 2.00M |
| 335 | PYXS | Pyxis Oncology, Inc. | 172.96M | -11.07% | 693,312 | 13.86M |
| 336 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 172.49M | -0.75% | 227,479 | - |
| 337 | IPHA | Innate Pharma S.A. | 170.31M | -5.26% | 1,945 | 10.57M |
| 338 | MIST | Milestone Pharmaceuticals Inc. | 169.38M | -3.49% | 2,049,349 | 1.78M |
| 339 | NRXP | NRx Pharmaceuticals, Inc. | 167.22M | -4.09% | 573,591 | 2.29M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 161.95M | -7.20% | 1,101,079 | - |
| 341 | TLSA | Tiziana Life Sciences Ltd | 161.63M | -0.79% | 52,725 | - |
| 342 | MENS | Jyong Biotech Ltd. | 159.60M | - | 30,911 | - |
| 343 | ANTX | AN2 Therapeutics, Inc. | 158.47M | 2.33% | 196,876 | - |
| 344 | MOLN | Molecular Partners AG | 148.70M | - | 366 | 856.30K |
| 345 | HURA | TuHURA Biosciences, Inc. | 145.20M | -1.56% | 299,351 | - |
| 346 | CUE | Cue Biopharma, Inc. | 144.34M | 2.92% | 77,581 | 32.73M |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 143.38M | -1.10% | 805,007 | - |
| 348 | KZIA | Kazia Therapeutics Limited | 142.38M | -1.53% | 92,984 | 1.27M |
| 349 | NMAD | NOMAD Power Solutions, Inc. | 141.22M | 13.61% | 429,180 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 139.78M | 0.45% | 672,242 | 233.00K |
| 351 | YDES | YD Bio Limited | 137.83M | -2.00% | 180,313 | 510.36K |
| 352 | PEPG | PepGen Inc. | 137.65M | -2.93% | 1,003,017 | - |
| 353 | SPRB | Spruce Biosciences, Inc. | 137.06M | -1.91% | 57,639 | 697.00K |
| 354 | AGEN | Agenus Inc. | 137.00M | -6.00% | 358,185 | 123.87M |
| 355 | VANI | Vivani Medical, Inc. | 130.65M | 12.22% | 1,407,493 | - |
| 356 | GNLX | Genelux Corporation | 129.45M | -1.85% | 94,516 | 8.00K |
| 357 | CBUS | Cibus, Inc. | 129.38M | 13.00% | 1,031,730 | 4.29M |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 128.18M | -4.71% | 1,443,806 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 125.73M | -5.91% | 243,463 | 7.94M |
| 360 | SPRO | Spero Therapeutics, Inc. | 125.65M | -0.46% | 147,203 | 61.19M |
| 361 | ENGN | enGene Therapeutics Inc. | 124.94M | -2.86% | 742,181 | - |
| 362 | PMN | ProMIS Neurosciences, Inc. | 123.57M | 1.70% | 67,267 | - |
| 363 | GUTS | Fractyl Health, Inc. | 121.38M | -3.88% | 389,487 | 3.00K |
| 364 | PLYX | Polaryx Therapeutics, Inc. | 120.73M | 0.79% | 61,413 | - |
| 365 | SEER | Seer, Inc. | 118.49M | -2.93% | 1,008,593 | 15.17M |
| 366 | ENLV | Enlivex Ltd. | 118.09M | -0.83% | 545,050 | - |
| 367 | AARD | Aardvark Therapeutics, Inc. | 115.19M | -2.21% | 94,095 | - |
| 368 | NTHI | NeOnc Technologies Holdings, Inc. | 113.07M | 0.23% | 13,177 | 39.99K |
| 369 | KLRS | Kalaris Therapeutics, Inc. | 112.06M | -2.48% | 64,583 | - |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 111.15M | 6.59% | 30,223 | 37.16M |
| 371 | BDTX | Black Diamond Therapeutics, Inc. | 108.87M | -8.65% | 1,754,393 | 70.00M |
| 372 | ANIX | Anixa Biosciences, Inc. | 105.81M | 5.07% | 184,627 | - |
| 373 | PYPD | PolyPid Ltd. | 99.90M | -2.25% | 211,430 | - |
| 374 | FBIO | Fortress Biotech, Inc. | 98.66M | -0.67% | 255,221 | 66.16M |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 98.32M | -1.24% | 1,019,617 | 65.34K |
| 376 | PTHS | Pelthos Therapeutics Inc. | 97.32M | 13.82% | 33,509 | 27.70M |
| 377 | ALPS | Alps Group Inc | 96.76M | -1.41% | 62,455 | 3.74M |
| 378 | CGTX | Cognition Therapeutics, Inc. | 95.76M | -6.02% | 2,243,326 | - |
| 379 | ICCC | ImmuCell Corporation | 95.76M | 2.37% | 26,202 | 29.93M |
| 380 | ONCY | Oncolytics Biotech Inc. | 94.56M | -3.32% | 716,335 | - |
| 381 | ACET | Adicet Bio, Inc. | 93.98M | 4.07% | 87,430 | - |
| 382 | BMEA | Biomea Fusion, Inc. | 93.27M | -7.86% | 1,282,675 | - |
| 383 | ATHE | Alterity Therapeutics Limited | 92.46M | 3.83% | 3,271 | 4.43M |
| 384 | RNTX | Rein Therapeutics Inc. | 90.23M | -3.98% | 76,770 | - |
| 385 | MAIA | MAIA Biotechnology, Inc. | 88.47M | -1.02% | 994,314 | - |
| 386 | OKYO | OKYO Pharma Limited | 87.64M | -4.57% | 558,175 | - |
| 387 | ATRA | Atara Biotherapeutics, Inc. | 86.95M | -5.75% | 89,668 | 23.14M |
| 388 | NRXS | NeurAxis, Inc. | 86.94M | -1.54% | 25,803 | 4.28M |
| 389 | RANI | Rani Therapeutics Holdings, Inc. | 85.47M | -2.74% | 451,381 | 3.17M |
| 390 | CRDF | Cardiff Oncology, Inc. | 85.46M | -7.41% | 907,075 | 525.00K |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 84.25M | -1.21% | 26,809 | - |
| 392 | ANVS | Annovis Bio, Inc. | 84.02M | 2.86% | 1,511,608 | - |
| 393 | RLYB | Rallybio Corporation | 83.02M | - | 5,542 | 858.00K |
| 394 | TCRX | TScan Therapeutics, Inc. | 82.34M | 17.76% | 2,615,953 | 9.14M |
| 395 | ENTX | Entera Bio Ltd. | 82.31M | 0.60% | 137,925 | 42.00K |
| 396 | GOSS | Gossamer Bio, Inc. | 81.86M | -5.66% | 8,595,610 | 55.54M |
| 397 | HRTX | Heron Therapeutics, Inc. | 81.62M | 1.29% | 1,374,872 | 150.71M |
| 398 | LONA | LeonaBio, Inc. | 81.44M | -0.80% | 20,026 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 81.32M | 2.15% | 506,197 | - |
| 400 | CSBR | Champions Oncology, Inc. | 78.46M | -3.91% | 6,753 | 57.95M |
| 401 | GANX | Gain Therapeutics, Inc. | 76.78M | -0.55% | 388,490 | - |
| 402 | IBIO | iBio, Inc. | 75.51M | -4.40% | 754,511 | 300.00K |
| 403 | PLRX | Pliant Therapeutics, Inc. | 71.90M | - | 211,620 | - |
| 404 | HYFT | MindWalk Holdings Corp. | 71.52M | -4.64% | 355,591 | 20.70M |
| 405 | XBIT | XBiotech Inc. | 71.34M | -1.68% | 18,973 | - |
| 406 | VRXA | Veraxa Biotech AG | 69.60M | -8.91% | 1,837,490 | - |
| 407 | MCRB | Seres Therapeutics, Inc. | 69.24M | -12.16% | 195,921 | 1.15M |
| 408 | MNOV | MediciNova, Inc. | 68.91M | -2.78% | 24,138 | 596.64K |
| 409 | BYSI | BeyondSpring Inc. | 68.67M | 0.60% | 24,643 | 1.88M |
| 410 | ELTX | Elicio Therapeutics, Inc. | 68.09M | 27.50% | 3,138,821 | - |
| 411 | IMA | ImageneBio, Inc. | 66.83M | -2.39% | 1,070 | 800.00K |
| 412 | EDSA | Edesa Biotech, Inc. | 66.47M | 2.40% | 19,731 | - |
| 413 | EXOZ | eXoZymes, Inc. | 66.31M | 2.89% | 5,244 | -700.00 |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 65.86M | -0.40% | 223,932 | - |
| 415 | CING | Cingulate Inc. | 65.19M | -4.91% | 831,415 | - |
| 416 | OSTX | OS Therapies Incorporated | 65.03M | -8.18% | 744,413 | - |
| 417 | ATYR | aTyr Pharma, Inc. | 63.06M | 6.10% | 2,377,655 | 190.00K |
| 418 | CNTX | Context Therapeutics Inc. | 57.06M | -11.29% | 2,232,695 | - |
| 419 | FLNA | Filana Therapeutics, Inc. | 57.00M | -9.92% | 666,664 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 55.52M | -0.32% | 65,011 | 53.48M |
| 421 | BOLD | Boundless Bio, Inc. | 55.03M | -2.00% | 135,141 | - |
| 422 | IMMP | Immutep Limited | 53.99M | -5.26% | 132,522 | 5.28M |
| 423 | INKT | MiNK Therapeutics, Inc. | 52.56M | 1.51% | 11,001 | - |
| 424 | TIL | Instil Bio, Inc. | 52.53M | -0.06% | 7,128 | - |
| 425 | ABVC | ABVC BioPharma, Inc. | 51.78M | 1.45% | 197,701 | 797.92K |
| 426 | MREO | Mereo BioPharma Group plc | 51.64M | -3.29% | 613,799 | 500.00K |
| 427 | ELOX | Eloxx Pharmaceuticals, Inc. | 49.44M | 11.87% | 42,731 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 49.00M | 2.03% | 11,023 | 10.86M |
| 429 | IBO | Impact BioMedical Inc. | 48.70M | - | 34,947 | 39.00K |
| 430 | MGX | Metagenomi Therapeutics, Inc. | 48.56M | -1.89% | 170,179 | 22.33M |
| 431 | DWTX | Dogwood Therapeutics, Inc. | 47.58M | -1.75% | 62,095 | - |
| 432 | TVRD | Tvardi Therapeutics, Inc. | 46.91M | 61.29% | 38,016,760 | - |
| 433 | INMB | INmune Bio Inc. | 46.52M | 0.57% | 480,791 | 50.00K |
| 434 | CRVO | CervoMed Inc. | 46.12M | -0.29% | 200,005 | 2.09M |
| 435 | HYPD | Hyperion DeFi, Inc. | 45.02M | 3.85% | 304,571 | 1.04M |
| 436 | PDSB | PDS Biotechnology Corporation | 44.56M | -4.41% | 244,020 | - |
| 437 | VERU | Veru Inc. | 43.01M | -6.94% | 352,487 | 16.89M |
| 438 | ALGS | Aligos Therapeutics, Inc. | 41.21M | 9.36% | 312,779 | 4.71M |
| 439 | APLM | Apollomics, Inc. | 41.07M | -1.22% | 6,099 | 8.84M |
| 440 | RNXT | RenovoRx, Inc. | 40.51M | -3.15% | 39,642 | 1.49M |
| 441 | LTRN | Lantern Pharma Inc. | 40.38M | -11.35% | 320,164 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 40.36M | -1.20% | 74,556 | - |
| 443 | ESLA | Estrella Immunopharma, Inc. | 38.73M | -1.11% | 13,125 | - |
| 444 | NTRB | Nutriband Inc. | 37.38M | 1.49% | 6,056 | 1.80M |
| 445 | DYAI | Dyadic International, Inc. | 37.06M | -4.05% | 164,130 | 3.81M |
| 446 | GNTA | Genenta Science S.p.A. | 36.33M | -4.35% | 37,889 | - |
| 447 | NNVC | NanoViricides, Inc. | 34.59M | 3.29% | 256,015 | - |
| 448 | LITS | Lite Strategy, Inc. | 33.24M | 0.59% | 98,130 | - |
| 449 | ACTU | Actuate Therapeutics, Inc. | 32.57M | -10.45% | 71,900 | - |
| 450 | SNTI | Senti Biosciences Holdings, Inc. | 32.39M | 2.97% | 80,908 | 38.00K |
| 451 | BCTX | BriaCell Therapeutics Corp. | 32.33M | 3.99% | 241,025 | - |
| 452 | SER | Serina Therapeutics, Inc. | 30.44M | -6.45% | 20,816 | 130.00K |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 30.43M | -7.62% | 72,433 | 90.00K |
| 454 | DARE | Daré Bioscience, Inc. | 30.41M | -0.98% | 82,463 | 1.16M |
| 455 | KYNB | Kyntra Bio, Inc. | 30.32M | -0.66% | 3,660 | 7.44M |
| 456 | LSTA | Lisata Therapeutics, Inc. | 29.23M | -1.83% | 17,542 | 170.00K |
| 457 | GRDX | GridAI Technologies Corp. | 28.61M | -1.15% | 49,997 | - |
| 458 | PLRZ | Polyrizon Ltd. | 27.98M | -1.97% | 33,336 | - |
| 459 | IGC | IGC Pharma, Inc. | 27.81M | -0.07% | 182,135 | 1.11M |
| 460 | EVAX | Evaxion A/S | 27.52M | -0.30% | 16,372 | 7.53M |
| 461 | MRKR | Marker Therapeutics, Inc. | 26.51M | -5.36% | 108,043 | 3.55M |
| 462 | PSTV | Plus Therapeutics, Inc. | 26.29M | -2.55% | 78,696 | 5.18M |
| 463 | KALA | KALA BIO, Inc. | 25.84M | -7.95% | 154,228 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 25.00M | -2.67% | 5,568 | 14.97M |
| 465 | SKYE | Skye Bioscience, Inc. | 24.85M | 0.53% | 16,264 | - |
| 466 | AKTX | Akari Therapeutics, Plc | 24.82M | -8.40% | 49,267 | - |
| 467 | NRSN | NeuroSense Therapeutics Ltd. | 24.39M | -2.56% | 42,143 | - |
| 468 | NCEL | NewcelX Ltd. | 22.77M | 5.49% | 72,049 | - |
| 469 | CVM | CEL-SCI Corporation | 22.72M | 1.56% | 98,481 | - |
| 470 | TVGN | Tevogen Bio Holdings Inc. | 22.03M | -4.36% | 13,584 | - |
| 471 | VYNE | VYNE Therapeutics Inc. | 21.81M | -2.37% | 15,951 | 454.00K |
| 472 | CELU | Celularity Inc. | 21.56M | 2.52% | 10,392 | 26.55M |
| 473 | CLRB | Cellectar Biosciences, Inc. | 21.14M | -2.04% | 22,155 | - |
| 474 | ATOS | Atossa Therapeutics, Inc. | 21.10M | -1.61% | 125,605 | - |
| 475 | ICU | SeaStar Medical Holding Corporation | 20.87M | 2.37% | 68,289 | 1.44M |
| 476 | PLUR | Pluri Inc. | 20.82M | -6.76% | 65,522 | 1.08M |
| 477 | LPCN | Lipocine Inc. | 20.32M | -0.20% | 6,551 | 2.00M |
| 478 | LGVN | Longeveron Inc. | 20.32M | 2.52% | 55,221 | 1.22M |
| 479 | QNTM | Quantum BioPharma Ltd. | 20.08M | -5.57% | 59,379 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 19.02M | -5.85% | 23,889 | -13.27K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 18.46M | 2.65% | 162,151 | 345.00K |
| 482 | PTN | Palatin Technologies, Inc. | 18.45M | -5.82% | 15,333 | 12.88M |
| 483 | AEON | AEON Biopharma, Inc. | 18.43M | 0.04% | 11,046 | - |
| 484 | HOWL | Werewolf Therapeutics, Inc. | 17.46M | 4.45% | 411,665 | 1.14M |
| 485 | QNCX | Quince Therapeutics, Inc. | 17.08M | -0.23% | 6,061 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 16.74M | -3.62% | 121,522 | - |
| 487 | GTBP | GT Biopharma, Inc. | 16.57M | -0.13% | 558,921 | - |
| 488 | BIVI | BioVie Inc. | 16.44M | 0.93% | 58,368 | - |
| 489 | MLEC | Moolec Science SA | 15.81M | -1.17% | 1,025 | 7.83M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 15.66M | -2.24% | 51,647 | 5.61M |
| 491 | PASG | Passage Bio, Inc. | 15.27M | -4.80% | 17,935 | - |
| 492 | HIND | Vyome Holdings, Inc. | 14.95M | -3.18% | 21,025 | 152.72K |
| 493 | TPST | Tempest Therapeutics, Inc. | 14.62M | 2.70% | 94,965 | - |
| 494 | CYCN | Cyclerion Therapeutics, Inc. | 14.59M | -1.15% | 5,300 | 1.99M |
| 495 | CALC | CalciMedica, Inc. | 14.53M | -3.76% | 177,170 | - |
| 496 | JSPR | Jasper Therapeutics, Inc. | 14.25M | 5.65% | 640,528 | - |
| 497 | INAB | IN8bio, Inc. | 13.88M | 1.44% | 20,111 | - |
| 498 | CMMB | Chemomab Therapeutics Ltd. | 13.82M | -30.69% | 1,856,677 | - |
| 499 | COCP | Cocrystal Pharma, Inc. | 13.54M | -1.96% | 10,319 | 225.00K |
| 500 | INTS | Intensity Therapeutics, Inc. | 13.28M | 2.82% | 32,616 | - |